Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes (1999)|April 29, 2009
A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir/lamivudine or tenofovir/emtricitabine in HIV-1-infected patients with virological suppressionEsteban Martínez, José A Arranz, Daniel Podzamczer, et al.
Infectious Diseases of Poverty|March 6, 2024
Male genitourinary schistosomiasis-related symptoms among long-term Western African migrants in Spain: a prospective population-based screening studySílvia Roure, Xavier Vallès, Olga Pérez-Quílez, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 26, 2017
Executive summary: Pre-exposure prophylaxis for prevention of HIV infection in adults in Spain: July 2016Santiago Moreno, Antonio Antela, Felipe García, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2020
Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019Dima Dandachi, Grant Geiger, Mary W Montgomery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 13, 2023
Plasma Human Immunodeficiency Virus 1 RNA and CD4+ T-Cell Counts Are Determinants of Virological Nonsuppression Outcomes With Initial Integrase Inhibitor-Based Regimens: A Prospective RESPOND Cohort StudyHortensia Álvarez, Amanda Mocroft, Lene Ryom, et al.
The Journal of Infection|August 4, 2024
Morbidity burden of imported chronic schistosomiasis among West African migrantsSílvia Roure, Xavier Vallès, Olga Pérez-Quílez, et al.
Plos One|December 31, 2020
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortiumBastian Neesgaard, Amanda Mocroft, Robert Zangerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2020
Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment-Experienced People Living With Human Immunodeficiency VirusLauren Greenberg, Lene Ryom, Bastian Neesgaard, et al.
The Lancet. HIV|September 23, 2021
Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortiumLoveleen Bansi-Matharu, Andrew Phillips, Cristiana Oprea, et al.
Cancers|July 29, 2023
Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIVLauren Greenberg, Lene Ryom, Elzbieta Bakowska, et al.
Pageof 17